rs141238034

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_000287.4(PEX6):​c.2644G>A​(p.Val882Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0259 in 1,614,138 control chromosomes in the GnomAD database, including 641 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 43 hom., cov: 32)
Exomes 𝑓: 0.026 ( 598 hom. )

Consequence

PEX6
NM_000287.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.61

Publications

10 publications found
Variant links:
Genes affected
PEX6 (HGNC:8859): (peroxisomal biogenesis factor 6) This gene encodes a member of the AAA (ATPases associated with diverse cellular activities) family of ATPases. This member is a predominantly cytoplasmic protein, which plays a direct role in peroxisomal protein import and is required for PTS1 (peroxisomal targeting signal 1, a C-terminal tripeptide of the sequence ser-lys-leu) receptor activity. Mutations in this gene cause peroxisome biogenesis disorders of complementation group 4 and complementation group 6. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PEX6 Gene-Disease associations (from GenCC):
  • peroxisome biogenesis disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • peroxisome biogenesis disorder 4A (Zellweger)
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Myriad Women’s Health
  • peroxisome biogenesis disorder 4B
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Heimler syndrome 2
    Inheritance: AR Classification: MODERATE Submitted by: G2P
  • autosomal recessive cerebellar ataxia-blindness-deafness syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Zellweger spectrum disorders
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 9 uncertain in NM_000287.4
BP4
Computational evidence support a benign effect (MetaRNN=0.009148866).
BP6
Variant 6-42965097-C-T is Benign according to our data. Variant chr6-42965097-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.021 (3197/152310) while in subpopulation NFE AF = 0.0274 (1866/68030). AF 95% confidence interval is 0.0264. There are 43 homozygotes in GnomAd4. There are 1648 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 43 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PEX6NM_000287.4 linkc.2644G>A p.Val882Ile missense_variant Exon 15 of 17 ENST00000304611.13 NP_000278.3 Q13608-1A0A024RD09

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PEX6ENST00000304611.13 linkc.2644G>A p.Val882Ile missense_variant Exon 15 of 17 1 NM_000287.4 ENSP00000303511.8 Q13608-1
PEX6ENST00000244546.4 linkc.*180G>A 3_prime_UTR_variant Exon 13 of 15 1 ENSP00000244546.4 Q13608-2

Frequencies

GnomAD3 genomes
AF:
0.0210
AC:
3202
AN:
152192
Hom.:
43
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00955
Gnomad AMI
AF:
0.0461
Gnomad AMR
AF:
0.00779
Gnomad ASJ
AF:
0.00922
Gnomad EAS
AF:
0.0233
Gnomad SAS
AF:
0.0254
Gnomad FIN
AF:
0.0444
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0274
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.0226
AC:
5690
AN:
251470
AF XY:
0.0234
show subpopulations
Gnomad AFR exome
AF:
0.00861
Gnomad AMR exome
AF:
0.00700
Gnomad ASJ exome
AF:
0.00595
Gnomad EAS exome
AF:
0.0239
Gnomad FIN exome
AF:
0.0403
Gnomad NFE exome
AF:
0.0266
Gnomad OTH exome
AF:
0.0239
GnomAD4 exome
AF:
0.0265
AC:
38684
AN:
1461828
Hom.:
598
Cov.:
34
AF XY:
0.0264
AC XY:
19178
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.00756
AC:
253
AN:
33480
American (AMR)
AF:
0.00736
AC:
329
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00627
AC:
164
AN:
26136
East Asian (EAS)
AF:
0.0163
AC:
649
AN:
39698
South Asian (SAS)
AF:
0.0251
AC:
2168
AN:
86254
European-Finnish (FIN)
AF:
0.0397
AC:
2121
AN:
53418
Middle Eastern (MID)
AF:
0.00867
AC:
50
AN:
5766
European-Non Finnish (NFE)
AF:
0.0284
AC:
31533
AN:
1111956
Other (OTH)
AF:
0.0235
AC:
1417
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2220
4439
6659
8878
11098
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1218
2436
3654
4872
6090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0210
AC:
3197
AN:
152310
Hom.:
43
Cov.:
32
AF XY:
0.0221
AC XY:
1648
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00950
AC:
395
AN:
41570
American (AMR)
AF:
0.00778
AC:
119
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00922
AC:
32
AN:
3472
East Asian (EAS)
AF:
0.0231
AC:
120
AN:
5186
South Asian (SAS)
AF:
0.0250
AC:
121
AN:
4832
European-Finnish (FIN)
AF:
0.0444
AC:
471
AN:
10598
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0274
AC:
1866
AN:
68030
Other (OTH)
AF:
0.0128
AC:
27
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
164
327
491
654
818
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0243
Hom.:
127
Bravo
AF:
0.0179
TwinsUK
AF:
0.0267
AC:
99
ALSPAC
AF:
0.0257
AC:
99
ESP6500AA
AF:
0.00862
AC:
38
ESP6500EA
AF:
0.0277
AC:
238
ExAC
AF:
0.0220
AC:
2665
Asia WGS
AF:
0.0230
AC:
79
AN:
3478
EpiCase
AF:
0.0256
EpiControl
AF:
0.0238

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jul 31, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 22, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 15, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Peroxisome biogenesis disorder 4A (Zellweger) Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Zellweger spectrum disorders Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Peroxisome biogenesis disorder Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
9.0
DANN
Benign
0.83
DEOGEN2
Benign
0.073
T
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.52
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0091
T
MetaSVM
Benign
-0.51
T
MutationAssessor
Benign
-0.77
N
PhyloP100
1.6
PrimateAI
Benign
0.35
T
PROVEAN
Benign
0.11
N
REVEL
Benign
0.29
Sift
Benign
1.0
T
Sift4G
Benign
0.63
T
Polyphen
0.46
P
Vest4
0.060
MPC
0.12
ClinPred
0.0090
T
GERP RS
2.6
Varity_R
0.021
gMVP
0.33
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2274516; hg19: chr6-42932835; API